New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
Saved in:
| Main Authors: | Filippos Panteleimon Chatzipieris, Athanasios Kokkalis, Nikitas Georgiou, Errikos Petsas, Ektoras Vasileios Apostolou, Georgios C. Vougioukalakis, Thomas Mavromoustakos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-06-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c00134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase-B for the Treatment of Alzheimer’s Disease
by: Ayesha Asim, et al.
Published: (2025-07-01) -
RNA G‑Quadruplex Reprogramming with Guanine-Rich Antisense Oligonucleotides Inhibits Monoamine Oxidase B’s Translation
by: Marc-Antoine Turcotte, et al.
Published: (2025-03-01) -
Elucidating the monoamine oxidase B inhibitory effect of kaurene diterpenoids from Xylopia aethiopica: An in silico approach.
by: Funmilayo Gladys Famuyiwa, et al.
Published: (2024-01-01) -
New class of thio/semicarbazide-based benzyloxy derivatives as selective class of monoamine oxidase-B inhibitors
by: Namitha Chandran, et al.
Published: (2024-12-01) -
Autoantibody profiling of autism spectrum disorder patients with monoamine oxidase a deficiency
by: Guan-Da Syu, et al.
Published: (2025-08-01)